wawang anwarudin. 2026. “Cost-Effectiveness Analysis of Rifampicin and Bedaquiline Use for Tuberculosis Treatment: A Systematic Review”. Journal of Health Economic and Policy Research (JHEPR) 4 (1):95-103. https://doi.org/10.30595/jhepr.v4i1.442.